Polymer Capital Management (Us) LLC Biocryst Pharmaceuticals Inc Transaction History
Polymer Capital Management (Us) LLC
- $388 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 29,290 shares of BCRX stock, worth $299,050. This represents 0.06% of its overall portfolio holdings.
Number of Shares
29,290Holding current value
$299,050% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
292Shares Held
176MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$221 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$204 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$91.2 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$88.8 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$79.8 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.9B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...